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Abstract Attention-deficit hyperactivity disorder is a
common condition in adulthood. The disorder is charac-
terized by symptoms of inattention, hyperactivity, and
impulsivity. Alongside these symptoms, it is discussed
whether symptoms of emotional dysregulation could add
additional and better description of the psychopathology of
ADHD. Neither the current ICD-10 and DSM-IV nor the
upcoming DSM-5 includes symptoms of emotional dys-
regulation as a core aspect of ADHD. Several authors (e.g.,
Wender 1995) describe adult ADHD in a more differenti-
ated way and propose concepts of the disorder that consider
the subjective experiences of the adult patient by intro-
ducing the symptomatology of emotional symptoms.
Empirical studies attest this dimension sufficient reliability
and validity. Symptoms of emotional dysregulation are
definable and seem to be distinct factors of the psychopa-
thology of adult ADHD. Pharmacological and psycho-
therapeutic interventions help to alleviate this type of
symptoms. This review attests a decisive role to the emo-
tional symptoms in the ADHD symptomatology, which
should be taken in serious consideration by future research.
Keywords ADHD in adults  Emotional dysregulation 
Wender–Reimherr Adult Attention Disorder Rating Scale 
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Introduction
Attention-deficit hyperactivity disorder (ADHD) in adult-
hood is a relatively new disorder. Until recently, it was still
presumed that children would grow out of this symptom-
atology at the latest upon termination of puberty. Now,
however, there is mounting evidence that the disorder can
persist into adulthood (Barkley 2006; Mannuzza et al.
1993; Murphy and Gordon 2006; Schmidt and Petermann
2008; Stieglitz et al. 2012). Epidemiological analyses have
shown that during adulthood the symptomatology can be
found as full or partial syndrome in 50 % of patients
(Faraone et al. 2006). Data from the World Health Orga-
nization (WHO) found a transnational prevalence of 3.4 %
for ADHD in adults (Fayyad et al. 2007). The diagnosis of
the disorder is a clinical one and represents the first chal-
lenge that has to be taken.
Classification of adult ADHD
The classification of adult ADHD follows the same princi-
ples as in child and adolescent psychiatry (Stieglitz and
Ro¨sler 2006). The 18 diagnostic criteria of DSM-IV or ICD-
10 are classified in three major symptom domains of inat-
tention, hyperactivity, and impulsivity. While for a diagnosis
based on ICD-10 a specific number of symptoms from all
three domains is needed, DSM-IV differentiates between
subtypes—the predominantly inattentive (314.00)—versus
the hyperactive–impulsive type (314.01), so that the corre-
sponding symptoms suffice. Only in the combined type
(314.01), the criteria for all three domains have to be fulfilled.
Besides the critique of the unsatisfactory picture repre-
sentation of the symptomatology of the adult ADHD in the
diagnostic criteria, there is an increasing discussion
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whether the tripartition inattention, hyperactivity, and
impulsivity is an adequate description of the full nature of
the adult ADHD (cf. e.g., Gibbins and Weiss 2007). On the
one hand, studies have demonstrated that these three psy-
chopathological dimensions are not stable over time (Bie-
derman et al. 2000; Faraone et al. 2006); on the other hand,
it is discussed whether further symptom domains can be
included in the description of the pathology of ADHD in
adulthood (Barkley and Murphy 2006). Another main
concern of these debates is the question to which extent
impairments ought to be seen as part of the area of affec-
tivity (Barkley and Murphy 2010). Thus, phenomena of
emotional dysregulation moved into the centre of attention.
The upcoming new DSM-5 conception of ADHD will
introduce many new diagnostic aspects, particularly for
adult ADHD. But there will be no change regarding the
three classical symptom domains of inattention, hyperac-
tivity, and impulsivity. Emotional dysregulation is not
planed to be included in the set of diagnostic criteria for
ADHD, as it is not seen as part of its core psychopathology.
For the assessment of emotional symptoms, the separate
category of ‘‘temper dysregulation with dysphoria’’ has
been considered in the chapter of disruptive disorders
(www.dsm5.org). However, there are different concepts of
the disorder that take into account the subjective experi-
ences of the adult patient. Figure 1 introduces the concepts
of Wender (1995; cf. also Ro¨sler et al. 2008a, b), Brown
(1996), Conners et al. (1999). As Fig. 1 shows that the
proposals of the various authors are different, but partly
overlapping with the central constructs of the disorder.
With regard to the question of the significance of emotional
dysregulation in adult ADHD, above all, the analyses of
Paul H. Wender (1995) are of outstanding importance. In
Fig 2, the conceptualization of the ADHD symptomatology
of Wender and their relation to ICD-10 or DSM-IV/DSM-
5, Brown, and Conners are demonstrated. According to the
Utah Criteria for ADHD in adults, the domain impulsivity,
in contrast to ICD-10 and DSM-IV/DSM-5, is not counted
among the core symptoms of ADHD, but only inattention
and hyperactivity, which are furthermore specified with the
aspect of restlessness. Impulsivity is, like disorganization
and the domain emotional dysregulation, only an additional
symptom domain. Emotional dysregulation is defined by
three subscales referring to temper control, affective
lability, and emotional overreactivity (synonym: stress
intolerance). Temper control refers to ‘‘feelings of irrita-
bility and frequent outbursts of short duration’’, affective
lability is associated with short and unpredictable ‘‘shifts
from normal mood to depression or mild excitement’’, and
emotional overreactivity refers to ‘‘a diminished ability to
handle typical life stresses, resulting in frequent feelings of
being hassled and overwhelmed’’ (Reimherr et al. 2005,
p. 125). While the dimensions hyperactivity and impul-
sivity are not part of the ADHD concept of Brown, DSM-
IV and DSM-5 do not consider the emotional spectrum of
the disorder. However, the Conners’ concept proposes two
domains impulsivity/emotional lability and problems with
self-concept as part of the emotional components of adult
ADHD; Brown’s model delineates the domain affective
interference as being an emotional component of the dis-
order as well.
Relevance of emotional dysregulation in adults
The significance of the conceptualization of emotional
dysregulation as a part of the symptomatology of ADHD is
justified from different perspectives: clinical, theoretical,
and empirical: clinical because patients’ statements time
and again suggest that the classic triad of ADHD symp-
toms, inattention, hyperactivity, and impulsivity, is not
sufficient to adequately describe the psychopathological
facets and functional impairment of patients suffering from
adult ADHD combined type. These patients consistently
report on mood swings, which significantly change more
rapidly than in affective disorders; that is, they may be
saddened for the day, or there may be several mood swings
a day, from elated to death. Patients have many problems to
Fig. 1 Dimensionality of
ADHD: different concepts
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deal with in stressful situations and are frequently and
quickly irritated by little things in everyday life (e.g. to get
angry fast). This is consistent with the theoretical findings:
it could be shown that there is an association of the clas-
sical ADHD symptoms not only with cognitive deficits and
neuroanatomical substrates, but also with mood variability
(cf. Skirrow et al. 2009). Of particular importance is,
moreover, the mounting empirical evidence for the sig-
nificance of symptoms of emotional dysregulation.
The aim of this article is to outline the concept of
emotional dysregulation in adult ADHD and to ascertain
the potential importance of this topic. Therefore, explicitly
those studies are explored that furnish empirical evidence
for emotional dysregulation and take in consideration these
symptoms in the concept of ADHD in adulthood. Particu-
larly, the reliability and the validity of the emotional
symptoms were investigated.
Empirical evidence for emotional dysregulation in adult
ADHD
The following review centres in detail on:
• Reliability
• Internal consistency
• Interrater reliability
• Validity
• Descriptive validity
• Factorial validity
• Convergent validity
• Divergent validity
• Measurement of change
• Treatment response
This is exemplified first of all by studies with the
Wender–Reimherr Adult Attention Disorder Rating Scale
(WRAADDS; Wender 1995; Ro¨sler et al. 2008a, b), which
has been designed according to the Utah Criteria for adult
ADHD. The WRAADDS assesses the domain of emotional
dysregulation as outlined above using three subscales:
affective lability, temper control, and emotional overreac-
tivity (cf. Fig. 2).
Reliability
In a summary of the psychometric properties of the Utah
Criteria, Reimherr et al. (2003) identified a Cronbach’s
a C .80 for the seven subscales of the WRAADDS. For the
subscales affective lability, temper control, and emotional
overreactivity that compose the domain emotional dys-
regulation, Ro¨sler et al. (2008a) found in a study compar-
ing different systems for the diagnosis of ADHD
satisfactory reliability (Cronbach’s a of .69, .68 and .61,
respectively). Corbisiero et al. (2010) found in their
research good reliability with a Cronbach’s a of .80, .76,
and .78, respectively.
While Ro¨sler et al. (2008a) determined the interrater
reliability of the WRAADDS at the level of the diagnosis
(Cohen’s Kappa j of 1.0), Corbisiero et al. (2010) explored
it at the level of the items (26 of 28 items were over j .60;
12 of 28 items even over j .81). Especially the coefficients
of the subscale temper control showed a very good inter-
rater reliability (j[ .88).
Descriptive validity
Descriptive validity refers to the differentiability and the
frequency of emotional dysregulation found in the analysed
studies. In two psychopharmacological studies of Reimherr
et al. (2005, 2007), 32 % (N = 529) and over 80 %
(N = 47) of all included patients met the criteria for
emotional dysregulation, respectively, defined by the
cluster of emotional symptoms on the WRAADDS. Robi-
son et al. (2008) used also the concept of emotional dys-
regulation derived from the Utah Criteria to analyse,
Fig. 2 Structure of the
Wender–Reimherr Adult
Attention Disorder Rating Scale
(WRAADDS)
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among other things, gender differences in baseline attri-
butes. 37 % of the female and 29 % of the male subjects
had elevations on these symptoms. In a sample of con-
secutive patients (N = 168), Ro¨sler et al. (2008a) demon-
strated that 16 of 28 WRAADDS items were identified in at
least 90 % of all patients, four of these items being part of
the domain of emotional dysregulation. These symptoms,
although numerically not that relevant, seem to have a
significant impact. In another analysis, Ro¨sler (2011) found
that eight of the 19 most frequent symptoms of ADHD with
a prevalence of at least 80 % of patients (N = 479) are
emotional symptoms. Reimherr et al. (2010) could identify
in a genetic study 73 % of subjects (n = 53; N = 80) with
emotional dysregulation in connection with adult ADHD.
In a sample of 540 patients assessed with the WRAADDS,
Corbisiero et al. (2010) describe all three subscales inher-
ent to the emotional dysregulation symptomatic. The
majority of the diagnosed persons with ADHD (n = 99,
34.1 %) showed impairments in all seven scales of the
WRAADDS. First of all, the subscale temper control
was numerously represented. Finally, in the study of
Robison et al. (2010), 72 % (n = 98; N = 136) of the
sample were categorized as ADHD patients with emotional
dysregulation.
Factorial validity
The dimensionality of the WRAADDS and its subscales
has already been analysed as well. Reimherr et al. (2003)
stated that factor analysis showed all seven areas to be
closely related; nevertheless, three factors could be sepa-
rated: symptoms of emotional dysregulation, inattentional/
disorganizational and hyperactive/impulsive symptoms.
Furthermore, Ro¨sler et al. (2008a, b) examined the factor
structure of the ADHD psychopathology represented by the
seven WRAADDS subscales with the three subscales of the
ADHD Self-Report (ADHD-SR; Ro¨sler et al. 2004). They
found a two-factor solution explaining for 63 % of the
variance, so that the subscales inherent to emotional dys-
regulation were designated as two different factors. Factor
1 comprised, besides affective lability, impulsivity,
hyperactivity, and temper control; factor 2 on the contrary
consisted of emotional overreactivity, inattention, and
disorganization. Corbisiero et al. (2010) conducted a
principal component analyses with varimax rotation to
determine the dimensionality of the WRAADDS. The
variance of the seven-factorial solution was 57.7 %.
Emotional dysregulation with its components affective
lability (9.1 %), temper control (7.9 %), and emotional
overreactivity (7.8 %) explained 24.8 % of the variance.
Furthermore, the analyses demonstrated that it was possible
to isolate the emotional dysregulation symptoms from the
other aspects of ADHD in adulthood, meaning that the
three domains of emotional dysregulation can easily be
distinguished from other domains of the ADHD symp-
tomatology (Stieglitz 2011).
Convergent validity
One of the most important aspects within the evaluation of
instruments for the assessment of psychopathological
ADHD traits refers to the convergent validity of the dif-
ferent concepts. This parameter tests whether constructs
that should be related are in fact related. The correspon-
dence of measures of similar constructs is high and low to
measures that assess dissimilar constructs. The convergent
validity of the WRAADDS subscales was examined in
several studies (cf. e.g. Corbisiero et al. 2010; Ro¨sler et al.
2008a, b). In the majority of the cases, the scales of the
WRAADDS were correlated with Conners’ Adult ADHD
Rating Scale for Raters (CAARS-R; Conners et al. 1999),
ADHS-SR, and Attention Deficit Hyperactivity Disorder
Diagnostic Checklist (ADHD-DC; Ro¨sler et al. 2004), for
example self- and observer-rating scales. The correlations
were moderate to strong. A few studies explicitly examined
the domain emotional dysregulation of the WRAADDS:
Reimherr et al. (2005) calculated substantial correlations
between the WRAADDS emotional dysregulation domain
and the subscales of the CAARS-R (attention r = .48 and
hyperactivity/impulsivity r = .48). Reimherr et al. (2010)
found a significant relationship between the three WRA-
ADDS factors attention ? disorganization, hyperactiv-
ity ? impulsivity, and emotional dysregulation. Emotional
dysregulation correlated with attention ? disorganization
(r = .38, n = 136, p \ .001) and hyperactivity ? impul-
sivity (r = .46, n = 136, p \ .001). In comparison, a
lower correlation was found in attention ? disorganization
with hyperactivity ? impulsivity (r = .28, n = 136,
p = .001). Stieglitz (2011) correlated all WRAADDS
scales with those of the CAARS-R (inattention, and
hyperactivity/impulsivity) and the ADHD-SR (inattention,
hyperactivity, and impulsivity). In most of the cases, the
WRAADDS subscales temper control, affective lability,
and emotional overreactivity had moderate correlations
with the other subscales of these instruments (cf. Table 1).
These findings show that emotional dysregulation repre-
sents a valid domain.
Divergent validity
The other aspect of construct validity, the divergent
validity, was investigated in a few studies. The objective
was to analyse whether emotional dysregulation in ADHD
is unrelated to other psychopathological features. Reimherr
et al. (2005) examined whether the comorbid subsyndromal
symptoms of depression and/or anxiety account for
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emotional dysregulation in ADHD adults. They used the
Hamilton Depression Rating Scale (HAM-D; Hamilton
1967) and the Hamilton Anxiety Rating Scale (HAM-A;
Hamilton 1959). Correlations between emotional dysreg-
ulation and assessment scores of the WRAADDS and
HAM-D (r = .30, n = 170)/HAM-A (r = .31, n = 170)
were moderate, that is, emotional dysregulation does not
reflect symptoms of anxiety or depression but is a distinct
symptomatology. Corbisiero et al. (2010) and Stieglitz
(2011) compared the subscales of the WRAADDS atten-
tion, hyperactivity, and impulsivity, and all subscales of the
WRAADDS, respectively, with the Eysenck Impulsivity
Questionnaire (I7; Eysenck et al. 1990). The two studies
were able to show that the subscales of the WRAADDS
had very low correlations with the subscales venture-
someness and empathy of I7 (r = .00–.16 and r =
-.15–.28, respectively). Even when the variable ‘‘age’’ was
added, the correlations of the subscales of the WRAADDS
were very low (r = .02–.11; Stieglitz 2011). Also these
findings emphasize the validity of the domain emotional
dysregulation. Moreover, they indicate that emotional
symptoms constitute an independent psychopathological
area of ADHD that can be distinguished from other psy-
chopathological construct.
Measurement of change
The subscales of the WRAADDS have already been taken
to measure changes in the ADHD symptomatology. The
sensitivity to measure change of the WRAADDS is com-
parable with that of ADHD-RS and ADHD-DC, which,
however, do not include measures of emotional dysregu-
lation, and the CAARS. In several psychopharmacological
studies, the sensitivity to measure change of the emotional
dysregulation domain was examined. The results were
satisfactory (Reimherr et al. 2005, 2007, 2010; Ro¨sler
et al. 2010). Reimherr et al. (2007) found in response to
atomoxetine (ATX) similar p values for the WRAADDS
and the ADHD-RS (p \ .001 for the total and the emo-
tional dysregulation score and p = .002 for only the total
score, respectively), and effect sizes were somewhat larger
for the WRAADDS (Cohen’s d = .70–93) in contrast to
the ADHD-RS (d = .69–.75). Reimherr et al. (2010) found
a significant positive correlation between change scores,
defined as the difference between active treatment and
placebo conditions. The correlation of the change scores
for emotional dysregulation with attention ? disorganiza-
tion and hyperactivity ? impulsivity was over .88 (n = 92,
p \ .001). In the treatment investigation with methylphe-
nidate (MPH) in adults with ADHD by Ro¨sler et al. (2010),
the researchers correlated the score of the Emotional
Dysregulation Scale (EDS: temper control, affect lability,
and emotional overreactivity) derived from the WRA-
ADDS with the Emotional Lability Scale (ELS) composed
of six items of the CAARS Self-Report, Long Form
(CAARS-L). At the end of the observation period (at week
24), the correlation between ELS and EDS was .81
(p \ .0001) in the placebo group and .67 (p \ .0001) in the
group treated with MPH.
Treatment response
In terms of clinical relevance, not only the classification of
the common versus the distinguishable features within the
entire spectrum of ADHD symptoms is of importance, but
especially the exploration of the extent to which the
symptoms of adult ADHD can be influenced by therapeutic
interventions. According to the evidence-based guidelines,
it is undisputed that psychopharmacological treatment with
MPH is actually the method of choice to treat inattention,
hyperactivity, and impulsivity in adults with ADHD (NICE
2008; Nutt et al. 2007). This recommendation is corrobo-
rated by different meta-analyses demonstrating the signif-
icant effect of stimulants and atomoxetine (ATX) on the
classical symptom triad (Castells et al. 2011; Faraone et al.
2004; Koesters et al. 2009; Meszaros et al. 2009). In regard
Table 1 Convergent validity (correlations) of emotional dysregulation domain with other ADHD scales
Study EDa measure Scale
CAARSb ADHS-SRc
Inad Hype/Impf Ina Hyp Imp
Reimherr et al. (2005) WRAADDSg ED .48*** .48*** – – –
Stieglitz (2011) WRAADDS
Temph .31*** .53*** .24*** .41*** .43***
Affecti .40 .41*** .32*** .33*** .33***
Overreactj .36*** .17*** .27*** .08* .13**
* p \ .10 **; p \ .01 ***; p \ .001; a emotional dysregulation, b Conners Adult ADHD Rating Scale, c ADHD Self-Report, d inattention,
e hyperactivity, f impulsivity, g Wender–Reimherr Adult Attention Disorder Rating Scale, h temper control, i affect lability, j emotional
overreactivity
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to the question whether the psychopathology of emotional
dysregulation is part of the disorder ADHD or, on the
contrary, is related to comorbid conditions or may be a
separate disorder all together, it may be of importance to
learn more about their therapeutic response to stimulants
and ATX. In a multicentre, placebo-controlled study with
596 patients taking ATX, Reimherr et al. (2005) exam-
ined the importance of the symptoms of emotional dys-
regulation. On the one hand, it was demonstrated that
about a third of the patients in the sampling who met the
psychopathological criteria of the dimension of emotional
dysregulation had a higher overall value in the ADHD
symptomatology at baseline, a lower response to placebo,
and a better response to ATX. On the other hand, it was,
among other aspects, concluded that the symptoms of
emotional dysregulation showed a similar treatment effect
as the classical three ADHD symptom areas. In the
measure of emotional dysregulation symptoms, patients
on ATX improved at week 10 in contrast to the placebo
group improvement. The effect size (Cohen’s d) of the
emotional dysregulation domain was the highest (d = .66,
p = .001) compared with the other domains. In a second
study by Reimherr et al. (2007) using MPH this time,
these findings were confirmed: the outcome for emotional
dysregulation as a function of treatment was with an
effect size of .70 in contrast to the higher score of the
placebo group. While the study of Reimherr et al. (2007)
had a short observation period of 4 weeks, in the study of
Ro¨sler et al. (2010) with 359 patients a duration of
24 weeks of treatment with MPH was chosen in order to
examine the medium- to long-term response and to study
a possible decline in effectivity over time. In this study,
the above-mentioned three areas were part of the EDS
consisting of the 10 items of the WRAADDS assessing
emotional symptoms. A significant decrease in emotional
symptoms as early as the 5th week onwards in patients
treated with extended release MPH (MPH-ER) was
detected. The treatment response was robust over time.
There was no evidence of a fading of the MPH-ER
effects even after 24 weeks. The MPH-ER treatment
group was significantly better than the placebo group
(d = .37). The results with the EDS were based on
information collected by observer ratings. When the
authors of the study used the emotional items of the
CAARS-L self-rating version, they found similar results
as compared with the WRAADDS-EDS. This means that
the positive therapeutic response of MPH-ER on the
psychopathology of emotional dysregulation can be
detected by self-reports of the patients and by observer
rating scales as well. Interestingly, the symptoms of
depression and anxiety as defined by the corresponding
subscales of the SCL-90-R (Derogatis 1977) did not
respond to MPH-ER treatment. In a recent controlled
study with 162 adults suffering from ADHD by Retz
et al. (2012), these findings were replicated. Patients with
ADHD demonstrated a significant improvement in
symptoms of emotional dysregulation in favour of MPH-
ER as compared with placebo. Even in this study,
symptoms of depression assessed by the Beck Depression
Inventory (BDI) did not show a significant treatment
response. This might be an argument for the view that the
symptoms of emotional dysregulation are not related to
comorbid affective disorders (Table 2).
Cognitive-behavioural treatment (CBT) seems to mini-
mize complaints and impairments due to emotional
symptoms in adult ADHD (cf. Elsa¨sser et al. 2010; Knouse
and Safren 2010; Safren et al. 2005). It is not clear, how-
ever, whether the emotional symptoms that respond are a
unique and distinct construct rather than reflecting dys-
phoria, low self-esteem, or self-efficacy co-occurring in
ADHD (Skirrow et al. 2009). It is also remarkable that in
some psychotherapeutic studies, emotional symptoms are
not explicitly defined but are seen as anger, symptoms of
anxiety, and depression and are mostly assessed with dif-
ferent non-specific ADHD scales (Bramham et al. 2009;
Safren et al. 2005; Stevenson et al. 2002). Safren et al.
(2005) proposed among others the two optional modules
anger and frustration management as well as communica-
tion skills, in which difficulties were treated that overlap
with those associated with emotional dysregulation defined
by the WRAADDS. Also Bramham et al. (2009) included
in their group cognitive-behavioural therapy modules on
emotion, the aspects of anger and frustration as well as
relationship skills that could in part be associated with
emotional dysregulation symptoms. Hesslinger et al.
(2002) adapted the dialectal behaviour therapy (DBT)
skills training group treatment of Marsha M. Linehan for
the treatment for ADHD in adults. This programme applied
explicitly emotional regulation skills as well as the group
Table 2 Effect sizes of emotional dysregulation scales measured in
psychopharmacological studies
Study Treatment N Measure ESa
EDb
Reimherr et al.
(2005)
ATXc 596 WRAADDSd .66**
Reimherr et al.
(2007)
OROS
MPHe
47 WRAADDS .70**
Ro¨sler et al. (2010) MPH-ERf 363 WRAADDS .37***
Retz et al. (2012) MPH-ER 162 WRAADDS .31*g
*p \ .05; ** p \ .001; ***p \ .0001; a effect size: Cohen’s d,
b emotional dysregulation in ADHD, c atomoxetine, d Wender–Re-
imherr Adult Attention Disorder Rating Scale, e osmotic release oral
system methylphenidate, f extended-release methylphenidate,
g affective lability
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therapy of Philipsen et al. (2007). They mentioned in their
group psychotherapy emotional regulation to be regarded
by patients (67.7 %) as one of the most helpful programme
topics. Rostain and Ramsay (2006) further examined the
effects of 6 months of medication combined with CBT.
Adults with ADHD receiving combined medication treat-
ment and CBT showed significant reductions in ADHD
symptoms assessed with the Brown Attention-Deficit Dis-
order Scale (BADDS, Brown 1996) observer report. Also,
the subscale emotion of the BADDS improved with sta-
tistical relevance (d = .47, N = 38, p \ .001). This sub-
scale is consistent with two subscales (affect lability and
temper control) of the WRAADDS (cf. Fig. 1). In the
research of Solanto et al. (2008), the effect size of the
BADDS (self report) subscale emotion was even very high
(d = .93, n = 30, p \ .001). In contrast with the other
subscales of the BADDS in both studies, the effect size of
the subscale emotion was the lowest, however. Finally,
Virta et al. (2008) treated emotional dysregulation assessed
with the BADDS (self report) in their cognitive-behavio-
urally oriented group rehabilitation programme. The
symptoms decreased with an effect size of d = .30. After 6
months (follow-up), no significant change of the total
BADDS symptoms was found (Salakari et al. 2010).
Unfortunately, the authors disregarded the emotional dys-
regulation symptoms in their follow-up study. In summary,
the data on CBT for adult ADHD suggest that psycho-
therapeutic interventions may play a role in effectively
treating this disorder. However, additional randomized
controlled studies are needed to elucidate the effects of
psychotherapy on the psychopathology of emotional dys-
regulation. So far, nearly all CBT treatments resulted in
large effect sizes (d = .80) on total ADHD symptoms
(Knouse and Safren 2010) (Table 3).
Conclusions and perspectives
The clinical picture of ADHD in adulthood is more com-
plex than previously thought. This has been demonstrated
by several studies. The three classical domains, inattention,
hyperactivity, and impulsivity, display only poorly the
complete spectrum of possible symptoms in adults.
It seems therefore necessary to expand this range. The debate
in recent years and the empirical results of different studies
suggest extending the spectrum of the ADHD psychopa-
thology to include the domain of emotional dysregulation,
which is, after all, a core feature of adult ADHD as
designed by Paul H. Wender (1995). Several studies have
shown that the areas of poor temper control, emotional
overreactivity, and affect lability are clinically relevant.
Not only do these symptoms cause considerable suffering
in the patients, but their prevalence is also similar to the
three classic symptom areas. Also in the ADHD construct
by Barkley (2006) the regulation of emotions plays an
important role. The five major constructs in his theory are:
inhibition, non-verbal working memory (self-directed
sensing, especially visual imagery), verbal working mem-
ory (self-directed private speech), reconstitution (gener-
ativity, problem-solving, and goal-directed inventiveness),
and emotional–motivational self-regulation. Barkley and
Murphy (2010) proposed the Emotional Impulsiveness
Scale (EIS, self- and other rating scale) to examine emo-
tional dysregulation that the authors define as emotional
impulsiveness. The symptoms of emotional impulsiveness
to be involved in ADHD according to Barkley and Murphy
(2010) are: (1) impatient; (2) quick to anger; (3) easily
frustrated; (4) overreact; (5) easily excited; (6) loose tem-
per; (7) touchy/annoyed. The EIS showed in the analyses
good psychometric properties: emotional impulsiveness
was considered as a single, unitary construct; the self-and
other rating scale of the EIS correlated highly with each
other, suggesting good external validity; also the associa-
tion of the scale with measures of functional impairment
occurring with ADHD symptoms alluded to external
validity. The seven symptoms of emotional impulsiveness
were present in a majority of the adults with ADHD, with a
significantly greater frequency than in the clinical control
group, and the community control group. Also the severity
of symptoms of emotional impulsiveness was significantly
greater in the patients with ADHD. The study concludes
that emotional dysregulation is a significant area of
symptom expression in ADHD. Barkley and Fischer (2010)
were able to replicate these results in another study eval-
uating emotional impulsiveness in hyperactive and control
children followed into adulthood.
A further central aspect underlining the importance of
emotional symptoms, which do not belong to the DSM-IV/
DSM-5 concept of ADHD, is their positive response to
Table 3 Effect sizes of emotional dysregulation scales measured in
psychotherapy studies
Study Treatment N Measure ESa
ADHD
EDb
Rostain and
Ramsay
(2006)
Combined treatment:
medication and CBTd
38 BADDS
(O)c
.47**
Solanto et al.
(2008)
30 BADDS
(S)e
.93**
Virta et al.
(2008)
Cognitive-behaviourally
oriented group
rehabilitation
29 BADDS
(S)
.30*
*p \ .05; ** p \ .001; a effect size: Cohne’s d, b emotional dysreg-
ulation, c Brown Attention Deficit Disorder Scale Observer Report,
d cognitive behavioural therapy, e Brown Attention-Deficit Disorder
Scale self-report
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psychopharmacological treatments with MPH or ATX. In
future studies using multivariate methods (e.g. latent class
analysis) it might be useful to examine whether there is any
one single subtype with predominant symptoms in the field
of emotional dysregulation.
Emotional dysregulation symptoms seems to be more
frequently in patients diagnosed with combined type
ADHD (Reimherr et al. 2005, 2010; Robison et al. 2008).
Genetic investigations could also clarify the role of emo-
tional dysregulation in adult ADHD. Robison et al. (2010)
used in their study emotional dysregulation as an additional
endophenotype to examine genes implicated in ADHD.
Eight single nucleotide polymorphisms (SNP) were geno-
typed. One SNP was significantly associated with emo-
tional dysregulation. The analysis of this SNP showed a
trend towards significance when using emotional dysreg-
ulation as an ADHD subtype. According to the researchers
this suggests that the different symptoms of ADHD might
be connected with specific genetic variants. In a recent
study Surman et al. (2011) conducted a family risk analysis
to clarify the familial relationship between ADHD and
deficient emotional self-regulation (DESR) in adults
defined from the Barkley Current Behaviour Scale, which
is comparable to the domain of emotional dysregulation of
the WRAADDS. Six of the eight items of this scale are
identical to items of EIS (Barkley and Fischer 2010)
mentioned above. Siblings of ADHD patients were at ele-
vated risk to have ADHD irrespective the presence or
absence of emotional dysregulation. Emotional dysregula-
tion symptomatology was only elevated among siblings of
adults with ADHD and identified DESR. Attention-deficit
hyperactivity disorder and DESR cosegregated in siblings.
The findings suggest, in accordance with the authors, that
emotional dysregulation may be a familial subtype of
ADHD. The authors indicated that the results of the study
cannot exclude contribution of non-axis-I DSM-IV disor-
ders to risk for emotional dysregulation and cannot deter-
mine whether the cosegregation of ADHD in DESR within
families is a consequence of genetic or environmental risk
factors.
Additionally, symptoms of emotional dysregulation in
adult ADHD seem to compromise the severity of the
ADHD symptomatology as well as its comorbid disorders
(e.g. sleeping problems, somatic complaints, anxiety-ten-
sion, oppositional-defiant symptoms) and impairments in
important domains of major life activities (Reimherr et al.
2005, 2007, 2010; Robison et al. 2008). Gender differences
were examined: Women with ADHD seem furthermore to
have a higher level of emotional symptoms. These symp-
toms would complicate the ADHD symptomatology and
may, particularly in women, obscure the diagnosis of
ADHD (Robison et al. 2008). Barkley and Murphy (2010)
argue that emotional dysregulation makes significant
contributions to impairment in numerous forms of major
life activities including social and occupational function-
ing, educational history, driving risk, criminal history,
marital satisfaction, parenting stress, and severity of off-
spring disruptive behaviour disorders. Even more, symp-
toms of emotional dysregulation contribute to impairments
in major life activities beyond those associated with the
traditional dimensions (inattention, hyperactivity, and
impulsivity) of ADHD symptoms (Barkley and Fischer
2010; Barkley and Murphy 2010).
In conclusion, emotional dysregulation symptoms and
scales show not only similar or even higher internal con-
sistencies than other symptoms and subscales of ADHD,
but also better interrater reliability. Aspects of emotional
dysregulation are further independent dimensions that can
be distinguished from other domains of ADHD symptom-
atology. The prevalence of emotional symptoms in adult
ADHD samples is on the same level as the classical ADHD
symptoms inattention, hyperactivity, and impulsivity.
Finally, emotional symptoms respond to MPH and ATX
treatment. The effect sizes of treatment regarding inatten-
tion, hyperactivity, impulsivity, and emotional dysregula-
tion are nearly identical. The emotional dysregulation
domain seems to be an important part of the psychopa-
thology of adult ADHD and contributes considerably to
impairments in most of the domains of major life activities,
besides leading to a more severe ADHD symptomatology.
The different concepts of ADHD and the various defini-
tions of emotional dysregulation complicate the compari-
son of studies. A uniform description and definition of
symptoms would be appropriate to provide both research-
ers and clinicians a clue to emotional dysregulation in adult
ADHD. DSM-IV/DSM-5 and ICD-10 classify inattention,
hyperactivity, and impulsivity as the core symptoms of
ADHD without mentioning emotional symptoms. How-
ever, the constructs by Wender, Brown, Conners, and
Barkley presented here attest a decisive role of the emo-
tional dysregulation domain in the ADHD symptomatology
and deserve more respect and consideration in future
research on ADHD.
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